Support for this comes from reports of the expression of SCF by certain glioma cell lines [18,19] and expression of c-kit, the tyrosine kinase receptor for SCF ligand, by neural stem/progenitor cells [15,20]. This evidence concerns the gene KITLG and central nervous system cancer.